Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology
Lindsay R. Meredith(University of California, Los Angeles), Lara A. Ray(University of California, Los Angeles), Han Du(University of California, Los Angeles), Elizabeth M. Burnette(University of California, Los Angeles), Wave‐Ananda Baskerville(University of California, Los Angeles), Molly Magill(Brown University), ReJoyce Green(Medical University of South Carolina), Erica N. Grodin(University of California, Los Angeles), Suzanna Donato(University of California, Los Angeles), Steven J. Nieto(University of Southern California)
Cited by 16
Related Papers
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
|The American Journal of Drug and Alcohol Abuse|2018|137
Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals
|Molecular Psychiatry|2017|125
Effects of varenicline on subjective craving and relative reinforcing value of cigarettes
|Drug and Alcohol Dependence|2018|64
Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis
|Addiction Biology|2019|60
Predictors of Substance Use Initiation by Early Adolescence
|American Journal of Psychiatry|2024|60